Cargando…
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
Background: Treatment guidelines recommend the tocilizumab use in patients with a CRP of >7.5 mg/dL. We aimed to estimate the causal effect of glucocorticoids + tocilizumab on mortality overall and after stratification for PaO(2)/FiO(2) ratio and CRP levels. Methods: This was an observational coh...
Autores principales: | Mussini, Cristina, Cozzi-Lepri, Alessandro, Meschiari, Marianna, Franceschini, Erica, Burastero, Giulia, Faltoni, Matteo, Franceschi, Giacomo, Iadisernia, Vittorio, Volpi, Sara, Dessilani, Andrea, Gozzi, Licia, Conti, Jacopo, Del Monte, Martina, Milic, Jovana, Borghi, Vanni, Tonelli, Roberto, Brugioni, Lucio, Romagnoli, Elisa, Pietrangelo, Antonello, Corradini, Elena, Girardis, Massimo, Busani, Stefano, Cossarizza, Andrea, Clini, Enrico, Guaraldi, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967307/ https://www.ncbi.nlm.nih.gov/pubmed/36851508 http://dx.doi.org/10.3390/v15020294 |
Ejemplares similares
-
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
por: Mussini, Cristina, et al.
Publicado: (2021) -
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
por: Meschiari, Marianna, et al.
Publicado: (2022) -
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study
por: Milic, Jovana, et al.
Publicado: (2021) -
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes
por: Guaraldi, Giovanni, et al.
Publicado: (2023) -
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
por: Mussini, Cristina, et al.
Publicado: (2021)